Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback

行业与产业 · 医药与生命科学 · cn · 来源:South China Morning Post · 2026-11-16 05:00

Shares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US Food and Drug Administration (FDA) rejected its cancer drug application, raising in

关键词:综合

原文链接:https://www.scmp.com/business/china-business/article/3374543/akeso-shares-plummet-chinese-firms-cancer-drug-ivonescimab-faces-fda-setback

本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/4b49ac3dac640045。

← 返回 · 硅基文明——先知首页 · 今日情报快照